GSK affirms its commitment to pharmaceutical manufacturing in Scotland

Significant investment in recent years confirms the company’s belief that Scotland is an excellent base for manufacture and export to global markets.

“GSK benefits through investment support, the Scottish economy benefits through the jobs and services created by a large business, and the people of Scotland and beyond benefit from the availability of world-class medicines made right here in Scotland.”

Les Thomson, site director at GSK Montrose

Why manufacture in Scotland?

Dave Tudor of global healthcare company, GSK, highlights three fundamentals when choosing a location for successful manufacturing – skills and resources, infrastructure and a fiscal strategy. Scotland has all three in abundance, making it a competitive place to manufacture for life and chemical sciences organisations.

Scotland is now

Whatever the company’s reasons for setting up shop in Scotland almost 65 years ago, today it’s the availability of a skilled workforce, an established supply chain backed by good infrastructure, government support and a strong academic culture that generates the company’s future talent pool that keeps them here.

The company describes Scotland as a country with a vibrant life sciences industry with strong industry leadership and skills availability. It also points to Scotland’s world-class universities and good transport links by road, rail and sea, and particularly strong air links to Europe and the United States.

Two factors make Scotland stand out

Innovation matters...

“You have to have a strong innovation or academic culture,” explains Dave. “What’s great about Scotland – over many decades now – we’ve created innovative products that are there to be manufactured.”

…and size matters.

“The size of Scotland makes it special. Because of the size we can get our hands around the government, the government agencies, the academic institutes and industry working in partnership and working in collaboration. So, when you put those fundamentals with these two unique selling points, it makes Scotland a very competitive place to manufacture.”

GSK’s sites in Scotland

GSK's link with Scotland began in 1952 with the opening of a new manufacturing plant in Montrose, and followed some 20 years later with a site in Irvine.

The company employs more than 100,000 people across the world - over 800 work at its two Scottish manufacturing plants, and a further 600 contractors support both sites.

The Irvine plant produces active ingredients which are used in two of the company’s leading antibiotics. It manufactures around 2,500 tonnes of active ingredients each year — enough to supply 700 million people with a week’s course of antibiotics.

On the east coast, the Montrose plant makes a range of active ingredients that are used to treat conditions including HIV/AIDS, respiratory diseases, hypertension, flu and dermatological diseases. Medicines that contain Montrose material are taken by over 20 million people around the world every day.

Room to grow in Irvine

GSK’s Irvine plant offers room for manufacturing to grow. It has increased its antibiotic capacity and is the single largest user of electricity of all GSK locations, so energy availability and costs are an important factor.

The company has invested significantly in improving the facilities at Irvine over the past five years. Renewable technologies such as biogas, a combined heat and power plant and two wind turbines have all contributed to helping the company secure its energy needs in a more environmentally responsible way.

A boost for Montrose 

The Montrose plant has been operating for almost 65 years. While pharmaceutical plants are designed to be long-lasting, there was a need to upgrade and refresh the plant. Like Irvine, significant investment has been made in the last five years. 

Moreover, in July 2016, GSK announced its plans for an additional multimillion pound investment in Montrose to create a new cutting-edge manufacturing facility.

Les Thomson, site director at Montrose said, “The investment commitment shown by GSK reflects the quality and professionalism of the people we have here. The site has a strong compliance culture and a track record of delivery to our patients."

The new facility replaced an existing building that manufactures respiratory active ingredients, providing long-term security for the site, and ensuring a continued supply of respiratory medicine to millions of patients around the world.

Support where it’s needed

GSK's position as a manufacturer with many decades’ experience in Scotland is reflected in the maturity of their relationship with Scottish Enterprise, Scotland's national economic development agency. GSK has a very strong account management process and relationship with Scottish Enterprise.

GSK describes this approach as a ‘win-win-win’ situation. The company says, “GSK benefits through investment support, the Scottish economy benefits through the jobs and services created by a large business and the people of Scotland and beyond benefit from the availability of world-class medicines made right here in Scotland.”

GSK also works with Skills Development Scotland (SDS), contributing to the Skills Investment Plan for life sciences. SDS supports GSK to help ensure the company has the specialist skills it needs as their Scottish plants develop.

In this section


California company, Xilinx has invested £4.9 million to develop technologies for wireless communication applications related to 5G.


HSBC, one of the world’s largest banking and financial services organisations, selected Scotland to establish a UK centre for its global risk and compliance operations.

Rooney Nimmo

Allan Rooney, a Scot in New York, didn't have to look far when expanding his legal firm with fellow Scot, John Nimmo. So, why were their Scottish roots so instrumental in growing their firm?


Discover why diabetes management leader, Dexcom, chose Edinburgh for its Europe, Middle East and Africa (EMEA) headquarters.


Skilled talent, access to risk capital and the support we offer to innovative companies, are among the top reasons that California satellite data specialists, Spire, chose to set up in Scotland.


China's iRes-Geo Technology Ltd opened its first Scottish base at Edinburgh's Heriot Watt University’s Research Park in 2016, taking on local talent to support its North Sea and global expansion plans.


Games and mobile developer Outplay Entertainment swapped the Golden Coast of California for the east coast of Scotland - here's why.


The world's first floating offshore wind farm is now in production, and will provide clean energy to 20,000 Scottish homes, thanks to £52.5 million Masdar partner investment in Scottish renewable power.


Steve Cassidy, Senior Vice President, Hilton UK & Ireland, talks about the progress of Scotland as a world-class business and leisure tourist destination and how easy and cost-effective it is to do business in Scotland.


Access to talent, skills training and digital technology helped London-based global business services firm, VeriCall choose Scotland as a location to scale up its operations.


Since opening its Global Centre of Excellence in August 2013, progressive global law firm Ashurst has found that Glasgow is the perfect location to expand its full range of business-critical functions. The firm is benefiting from the city’s high calibre graduates to help transform how it delivers its legal services to its clients across the globe.


Locating one of its research and development hubs in Dundee, Scotland, has delivered unexpected benefits for Colorado-based software business Cherwell.


A vision to digitally disrupt the outsourcing market has led to the rapid expansion of Scottish outsourcing firm, Ascensos. The company’s success is further proof that Scotland is the place to be to do great things digitally. For access to data science talent, ongoing business support and technology partnerships to develop your global business services, think Scotland.

Join one of the largest life sciences clusters in Europe, with over 600 life sciences organisations.